Giardiasis is an intestinal infection that is caused by Giardia duodenalis protozoa. It is prevalent in low-income areas, and it frequently manifests as flatulence and diarrhea with mucus. The disease is particularly prevalent among overseas tourists, wilderness adventurers, and daycare workers in the United States. Though frequently asymptomatic, some individuals may lose weight or get dehydrated due to this illness. In many cases, treatment with anthelmintics or nitroimidazole drugs can cure the disease.
Epidemiology
Approximately 2% of adults and 8% of children in developed countries suffer from giardiasis, the most common enteric protozoal infection in the world. Additionally, an estimated 33% of individuals in underdeveloped nations are plagued with this disease. As asymptomatic carriers, most cases remain unidentified in the United States, resulting in an estimated prevalence of 1.2 million cases. In 2012, the CDC recorded 15,223 cases. Children up to the age of 4 were the most affected demographic, with the northwest US reporting the highest proportion of cases. Because of outdoor water activities, late summer and early fall have the highest prevalence.
Protozoa are transmitted via the fecal-oral route, typically by the consumption of contaminated food or water. It can also be transmitted from person to person or, less frequently, from animal to person. An infected person can shed between 108 and 1010 cysts per day, although even 10 cysts can constitute an infectious dose. Carriers of a subclinical illness are able to infect others. Populations at risk in the United States include international tourists, wilderness travelers, daycare workers, males who have sex with other men, and individuals who work with human feces.
Anatomy
Pathophysiology
The cause of giardiasis symptoms is not completely understood. Trophozoites use their ventral disc to cling to the gut wall. Researchers hypothesize that protozoa affect epithelial cell connections and brush border enzymes in the small intestine. Patients affected may exhibit impaired gastrointestinal motility. The protozoa secrete lectins and thiol proteinases which are cytotoxic. This interaction increases permeability and lowers the capacity to digest saccharides.
Etiology
Giardia duodenalis is the protozoa that causes giardiasis. It is also commonly called Giardia intesinalis and Giardia lamblia. Cysts are released by infected animals into freshwater where they can remain infective for weeks or months. Only genotypes A and B are known to infect humans out of seven genetic assemblages (A-F).
Inadequate sanitation and hygiene have a crucial role in disease transmission. Today, daycares have become epicenters of the virus, primarily because of insufficient handwashing when changing diapers or handling such waste. In the intestinal tract, the cysts undergo excystation and then release trophozoites. Trophozoites are flagellated, pear-shaped protozoa which contain two nuclei.
Genetics
Prognostic Factors
Most cases of Giardiasis are asymptomatic and require no medical interventions. Antihelmintics drugs are prescribed to patients if they suffer from severe symptoms. Even severe cases generally present a good prognosis and undergo a rapid recovery after receiving medication.
Clinical History
Age Group:
Children (0–10 years)
Most affected group: Children, especially those in daycare or preschool settings, are at the highest risk due to close contact with other children and poor hand hygiene.
Adolescents (10–18 years)
Moderate risk: This age group may encounter giardiasis during travel to endemic areas, outdoor activities (e.g., camping, hiking), or consuming untreated water.
Older Adults (65+ years)
Lower prevalence but increased severity: Older adults are less likely to contract giardiasis but may experience more severe symptoms due to pre-existing health conditions or a weakened immune system.
Physical Examination
Abdominal Examination
Signs of Dehydration
Nutritional Status
Rectal Examination
Age group
Associated comorbidity
Malabsorption Syndrome
Irritable Bowel Syndrome (IBS):
Lactose Intolerance
Chronic Fatigue Syndrome
Recurrent Infections
Associated activity
Acuity of presentation
Acute Presentation
Symptoms typically appear 1–3 weeks after exposure.
Common symptoms include:
Watery diarrhea (often foul-smelling)
Abdominal cramps or bloating
Nausea and vomiting
Fatigue or malaise
Weight loss
Some individuals experience significant dehydration due to severe diarrhea.
Chronic or Subacute Presentation
Occurs if the infection persists beyond the acute phase, especially in untreated individuals.
Symptoms may include:
Prolonged diarrhea (often greasy or floating stools due to malabsorption)
Malnutrition and weight loss
Vitamin deficiencies (e.g., fat-soluble vitamins A, D, E, K)
Fatigue and general malaise
Chronic infections are more common in immunocompromised individuals or in settings of repeated exposure (e.g., endemic areas).
Asymptomatic Presentation
Some individuals, particularly in endemic areas, may harbor the parasite without overt symptoms.
These carriers can still shed cysts in their stool, contributing to the spread of the infection.
Clinical Symptoms: Diarrhea (often foul-smelling and greasy), abdominal cramps, bloating, nausea, and fatigue.
Diagnostic Tests:
Stool Analysis: Microscopic examination or antigen detection tests.
Nucleic Acid Tests (NATs): PCR-based assays for high sensitivity and specificity.
First-Line Treatment
Nitroimidazole Class:
Metronidazole (250–750 mg orally, three times daily for 5–7 days)
Most used; effective and affordable.
Tinidazole (2 g orally, single dose)
Similar efficacy to metronidazole but with a shorter duration.
Alternative Therapies
Nitazoxanide:
500 mg orally, twice daily for 3 days.
Particularly useful in pediatric populations and those who cannot tolerate nitroimidazoles.
Albendazole:
400 mg orally, once daily for 5 days.
Effective against Giardia and other parasitic infections (e.g., nematodes).
Supportive Care
Hydration: Address dehydration caused by diarrhea.
Oral rehydration solutions (ORS) or intravenous fluids in severe cases.
Nutritional Support: Restore nutrients lost due to malabsorption.
Public Health Measures
Prevention:
Safe drinking water (boiling or filtration to remove cysts).
Good personal hygiene and sanitation.
Avoiding raw or untreated water during travel to endemic areas.
Household Screening: For symptomatic close contacts, as Giardia is highly contagious.
by Stage
by Modality
Chemotherapy
Radiation Therapy
Surgical Interventions
Hormone Therapy
Immunotherapy
Hyperthermia
Photodynamic Therapy
Stem Cell Transplant
Targeted Therapy
Palliative Care
lifestyle-modifications-in-treating-giardiasis
Water Safety
Boil Drinking Water: If using untreated water sources, boiling is effective in killing Giardia.
Install Filters: Use water filters certified to remove Giardia cysts (pore size ≤ 1 micron).
Disinfect Water: Use chlorine dioxide or iodine tablets as per the manufacturer’s instructions.
Maintain Water Supply Systems: Regularly inspect and repair leaks in water systems to prevent contamination.
Sanitation Improvements
Proper Sewage Disposal: Ensure proper treatment and disposal of sewage to avoid contaminating water sources.
Avoid Open Defecation: Promote the use of latrines or toilets in areas lacking sanitation infrastructure.
Maintain Clean Living Areas: Regularly clean and sanitize shared spaces, especially in childcare centers.
Effectiveness of Antiprotozoal agents in treating Giardiasis
Metronidazole
Dosage: Typically, 250-500 mg three times daily for 5-7 days (adults).
Most used, though it may cause a metallic taste or nausea.
Tinidazole
Dosage: A single dose of 2 g (adults) or weight-based dosing for children.
Notes: Highly effective, like metronidazole but with a simpler dosing regimen.
Nitazoxanide
Dosage: 500 mg twice daily for 3 days (adults); weight-based for children.
Well-tolerated and effective, particularly in pediatric cases.
role-of-management-in-treating-giardiasis
Diagnosis: Identifying the infection through stool tests (e.g., antigen detection, microscopy) to confirm the presence of Giardia cysts or trophozoites.
Acute Treatment: Administering appropriate anti-parasitic medications, such as metronidazole, tinidazole, or nitazoxanide, to kill the Giardia organisms.
Symptom Management: Addressing symptoms like diarrhea, abdominal pain, and bloating with supportive care, including rehydration and electrolyte balance.
Follow-Up: Monitoring for resolution of symptoms and re-testing if needed, especially if symptoms persist or recur.
Prevention: Advising on hygiene practices, safe drinking water, and avoiding contaminated food to prevent re-infection or spread.
Giardiasis is an intestinal infection that is caused by Giardia duodenalis protozoa. It is prevalent in low-income areas, and it frequently manifests as flatulence and diarrhea with mucus. The disease is particularly prevalent among overseas tourists, wilderness adventurers, and daycare workers in the United States. Though frequently asymptomatic, some individuals may lose weight or get dehydrated due to this illness. In many cases, treatment with anthelmintics or nitroimidazole drugs can cure the disease.
Approximately 2% of adults and 8% of children in developed countries suffer from giardiasis, the most common enteric protozoal infection in the world. Additionally, an estimated 33% of individuals in underdeveloped nations are plagued with this disease. As asymptomatic carriers, most cases remain unidentified in the United States, resulting in an estimated prevalence of 1.2 million cases. In 2012, the CDC recorded 15,223 cases. Children up to the age of 4 were the most affected demographic, with the northwest US reporting the highest proportion of cases. Because of outdoor water activities, late summer and early fall have the highest prevalence.
Protozoa are transmitted via the fecal-oral route, typically by the consumption of contaminated food or water. It can also be transmitted from person to person or, less frequently, from animal to person. An infected person can shed between 108 and 1010 cysts per day, although even 10 cysts can constitute an infectious dose. Carriers of a subclinical illness are able to infect others. Populations at risk in the United States include international tourists, wilderness travelers, daycare workers, males who have sex with other men, and individuals who work with human feces.
The cause of giardiasis symptoms is not completely understood. Trophozoites use their ventral disc to cling to the gut wall. Researchers hypothesize that protozoa affect epithelial cell connections and brush border enzymes in the small intestine. Patients affected may exhibit impaired gastrointestinal motility. The protozoa secrete lectins and thiol proteinases which are cytotoxic. This interaction increases permeability and lowers the capacity to digest saccharides.
Giardia duodenalis is the protozoa that causes giardiasis. It is also commonly called Giardia intesinalis and Giardia lamblia. Cysts are released by infected animals into freshwater where they can remain infective for weeks or months. Only genotypes A and B are known to infect humans out of seven genetic assemblages (A-F).
Inadequate sanitation and hygiene have a crucial role in disease transmission. Today, daycares have become epicenters of the virus, primarily because of insufficient handwashing when changing diapers or handling such waste. In the intestinal tract, the cysts undergo excystation and then release trophozoites. Trophozoites are flagellated, pear-shaped protozoa which contain two nuclei.
Most cases of Giardiasis are asymptomatic and require no medical interventions. Antihelmintics drugs are prescribed to patients if they suffer from severe symptoms. Even severe cases generally present a good prognosis and undergo a rapid recovery after receiving medication.
Age Group:
Children (0–10 years)
Most affected group: Children, especially those in daycare or preschool settings, are at the highest risk due to close contact with other children and poor hand hygiene.
Adolescents (10–18 years)
Moderate risk: This age group may encounter giardiasis during travel to endemic areas, outdoor activities (e.g., camping, hiking), or consuming untreated water.
Older Adults (65+ years)
Lower prevalence but increased severity: Older adults are less likely to contract giardiasis but may experience more severe symptoms due to pre-existing health conditions or a weakened immune system.
Abdominal Examination
Signs of Dehydration
Nutritional Status
Rectal Examination
Malabsorption Syndrome
Irritable Bowel Syndrome (IBS):
Lactose Intolerance
Chronic Fatigue Syndrome
Recurrent Infections
Acute Presentation
Symptoms typically appear 1–3 weeks after exposure.
Common symptoms include:
Watery diarrhea (often foul-smelling)
Abdominal cramps or bloating
Nausea and vomiting
Fatigue or malaise
Weight loss
Some individuals experience significant dehydration due to severe diarrhea.
Chronic or Subacute Presentation
Occurs if the infection persists beyond the acute phase, especially in untreated individuals.
Symptoms may include:
Prolonged diarrhea (often greasy or floating stools due to malabsorption)
Malnutrition and weight loss
Vitamin deficiencies (e.g., fat-soluble vitamins A, D, E, K)
Fatigue and general malaise
Chronic infections are more common in immunocompromised individuals or in settings of repeated exposure (e.g., endemic areas).
Asymptomatic Presentation
Some individuals, particularly in endemic areas, may harbor the parasite without overt symptoms.
These carriers can still shed cysts in their stool, contributing to the spread of the infection.
Clinical Symptoms: Diarrhea (often foul-smelling and greasy), abdominal cramps, bloating, nausea, and fatigue.
Diagnostic Tests:
Stool Analysis: Microscopic examination or antigen detection tests.
Nucleic Acid Tests (NATs): PCR-based assays for high sensitivity and specificity.
First-Line Treatment
Nitroimidazole Class:
Metronidazole (250–750 mg orally, three times daily for 5–7 days)
Most used; effective and affordable.
Tinidazole (2 g orally, single dose)
Similar efficacy to metronidazole but with a shorter duration.
Alternative Therapies
Nitazoxanide:
500 mg orally, twice daily for 3 days.
Particularly useful in pediatric populations and those who cannot tolerate nitroimidazoles.
Albendazole:
400 mg orally, once daily for 5 days.
Effective against Giardia and other parasitic infections (e.g., nematodes).
Supportive Care
Hydration: Address dehydration caused by diarrhea.
Oral rehydration solutions (ORS) or intravenous fluids in severe cases.
Nutritional Support: Restore nutrients lost due to malabsorption.
Public Health Measures
Prevention:
Safe drinking water (boiling or filtration to remove cysts).
Good personal hygiene and sanitation.
Avoiding raw or untreated water during travel to endemic areas.
Household Screening: For symptomatic close contacts, as Giardia is highly contagious.
Gastroenterology
Water Safety
Boil Drinking Water: If using untreated water sources, boiling is effective in killing Giardia.
Install Filters: Use water filters certified to remove Giardia cysts (pore size ≤ 1 micron).
Disinfect Water: Use chlorine dioxide or iodine tablets as per the manufacturer’s instructions.
Maintain Water Supply Systems: Regularly inspect and repair leaks in water systems to prevent contamination.
Sanitation Improvements
Proper Sewage Disposal: Ensure proper treatment and disposal of sewage to avoid contaminating water sources.
Avoid Open Defecation: Promote the use of latrines or toilets in areas lacking sanitation infrastructure.
Maintain Clean Living Areas: Regularly clean and sanitize shared spaces, especially in childcare centers.
Gastroenterology
Metronidazole
Dosage: Typically, 250-500 mg three times daily for 5-7 days (adults).
Most used, though it may cause a metallic taste or nausea.
Tinidazole
Dosage: A single dose of 2 g (adults) or weight-based dosing for children.
Notes: Highly effective, like metronidazole but with a simpler dosing regimen.
Nitazoxanide
Dosage: 500 mg twice daily for 3 days (adults); weight-based for children.
Well-tolerated and effective, particularly in pediatric cases.
Gastroenterology
Diagnosis: Identifying the infection through stool tests (e.g., antigen detection, microscopy) to confirm the presence of Giardia cysts or trophozoites.
Acute Treatment: Administering appropriate anti-parasitic medications, such as metronidazole, tinidazole, or nitazoxanide, to kill the Giardia organisms.
Symptom Management: Addressing symptoms like diarrhea, abdominal pain, and bloating with supportive care, including rehydration and electrolyte balance.
Follow-Up: Monitoring for resolution of symptoms and re-testing if needed, especially if symptoms persist or recur.
Prevention: Advising on hygiene practices, safe drinking water, and avoiding contaminated food to prevent re-infection or spread.
Giardiasis is an intestinal infection that is caused by Giardia duodenalis protozoa. It is prevalent in low-income areas, and it frequently manifests as flatulence and diarrhea with mucus. The disease is particularly prevalent among overseas tourists, wilderness adventurers, and daycare workers in the United States. Though frequently asymptomatic, some individuals may lose weight or get dehydrated due to this illness. In many cases, treatment with anthelmintics or nitroimidazole drugs can cure the disease.
Approximately 2% of adults and 8% of children in developed countries suffer from giardiasis, the most common enteric protozoal infection in the world. Additionally, an estimated 33% of individuals in underdeveloped nations are plagued with this disease. As asymptomatic carriers, most cases remain unidentified in the United States, resulting in an estimated prevalence of 1.2 million cases. In 2012, the CDC recorded 15,223 cases. Children up to the age of 4 were the most affected demographic, with the northwest US reporting the highest proportion of cases. Because of outdoor water activities, late summer and early fall have the highest prevalence.
Protozoa are transmitted via the fecal-oral route, typically by the consumption of contaminated food or water. It can also be transmitted from person to person or, less frequently, from animal to person. An infected person can shed between 108 and 1010 cysts per day, although even 10 cysts can constitute an infectious dose. Carriers of a subclinical illness are able to infect others. Populations at risk in the United States include international tourists, wilderness travelers, daycare workers, males who have sex with other men, and individuals who work with human feces.
The cause of giardiasis symptoms is not completely understood. Trophozoites use their ventral disc to cling to the gut wall. Researchers hypothesize that protozoa affect epithelial cell connections and brush border enzymes in the small intestine. Patients affected may exhibit impaired gastrointestinal motility. The protozoa secrete lectins and thiol proteinases which are cytotoxic. This interaction increases permeability and lowers the capacity to digest saccharides.
Giardia duodenalis is the protozoa that causes giardiasis. It is also commonly called Giardia intesinalis and Giardia lamblia. Cysts are released by infected animals into freshwater where they can remain infective for weeks or months. Only genotypes A and B are known to infect humans out of seven genetic assemblages (A-F).
Inadequate sanitation and hygiene have a crucial role in disease transmission. Today, daycares have become epicenters of the virus, primarily because of insufficient handwashing when changing diapers or handling such waste. In the intestinal tract, the cysts undergo excystation and then release trophozoites. Trophozoites are flagellated, pear-shaped protozoa which contain two nuclei.
Most cases of Giardiasis are asymptomatic and require no medical interventions. Antihelmintics drugs are prescribed to patients if they suffer from severe symptoms. Even severe cases generally present a good prognosis and undergo a rapid recovery after receiving medication.
Age Group:
Children (0–10 years)
Most affected group: Children, especially those in daycare or preschool settings, are at the highest risk due to close contact with other children and poor hand hygiene.
Adolescents (10–18 years)
Moderate risk: This age group may encounter giardiasis during travel to endemic areas, outdoor activities (e.g., camping, hiking), or consuming untreated water.
Older Adults (65+ years)
Lower prevalence but increased severity: Older adults are less likely to contract giardiasis but may experience more severe symptoms due to pre-existing health conditions or a weakened immune system.
Abdominal Examination
Signs of Dehydration
Nutritional Status
Rectal Examination
Malabsorption Syndrome
Irritable Bowel Syndrome (IBS):
Lactose Intolerance
Chronic Fatigue Syndrome
Recurrent Infections
Acute Presentation
Symptoms typically appear 1–3 weeks after exposure.
Common symptoms include:
Watery diarrhea (often foul-smelling)
Abdominal cramps or bloating
Nausea and vomiting
Fatigue or malaise
Weight loss
Some individuals experience significant dehydration due to severe diarrhea.
Chronic or Subacute Presentation
Occurs if the infection persists beyond the acute phase, especially in untreated individuals.
Symptoms may include:
Prolonged diarrhea (often greasy or floating stools due to malabsorption)
Malnutrition and weight loss
Vitamin deficiencies (e.g., fat-soluble vitamins A, D, E, K)
Fatigue and general malaise
Chronic infections are more common in immunocompromised individuals or in settings of repeated exposure (e.g., endemic areas).
Asymptomatic Presentation
Some individuals, particularly in endemic areas, may harbor the parasite without overt symptoms.
These carriers can still shed cysts in their stool, contributing to the spread of the infection.
Clinical Symptoms: Diarrhea (often foul-smelling and greasy), abdominal cramps, bloating, nausea, and fatigue.
Diagnostic Tests:
Stool Analysis: Microscopic examination or antigen detection tests.
Nucleic Acid Tests (NATs): PCR-based assays for high sensitivity and specificity.
First-Line Treatment
Nitroimidazole Class:
Metronidazole (250–750 mg orally, three times daily for 5–7 days)
Most used; effective and affordable.
Tinidazole (2 g orally, single dose)
Similar efficacy to metronidazole but with a shorter duration.
Alternative Therapies
Nitazoxanide:
500 mg orally, twice daily for 3 days.
Particularly useful in pediatric populations and those who cannot tolerate nitroimidazoles.
Albendazole:
400 mg orally, once daily for 5 days.
Effective against Giardia and other parasitic infections (e.g., nematodes).
Supportive Care
Hydration: Address dehydration caused by diarrhea.
Oral rehydration solutions (ORS) or intravenous fluids in severe cases.
Nutritional Support: Restore nutrients lost due to malabsorption.
Public Health Measures
Prevention:
Safe drinking water (boiling or filtration to remove cysts).
Good personal hygiene and sanitation.
Avoiding raw or untreated water during travel to endemic areas.
Household Screening: For symptomatic close contacts, as Giardia is highly contagious.
Gastroenterology
Water Safety
Boil Drinking Water: If using untreated water sources, boiling is effective in killing Giardia.
Install Filters: Use water filters certified to remove Giardia cysts (pore size ≤ 1 micron).
Disinfect Water: Use chlorine dioxide or iodine tablets as per the manufacturer’s instructions.
Maintain Water Supply Systems: Regularly inspect and repair leaks in water systems to prevent contamination.
Sanitation Improvements
Proper Sewage Disposal: Ensure proper treatment and disposal of sewage to avoid contaminating water sources.
Avoid Open Defecation: Promote the use of latrines or toilets in areas lacking sanitation infrastructure.
Maintain Clean Living Areas: Regularly clean and sanitize shared spaces, especially in childcare centers.
Gastroenterology
Metronidazole
Dosage: Typically, 250-500 mg three times daily for 5-7 days (adults).
Most used, though it may cause a metallic taste or nausea.
Tinidazole
Dosage: A single dose of 2 g (adults) or weight-based dosing for children.
Notes: Highly effective, like metronidazole but with a simpler dosing regimen.
Nitazoxanide
Dosage: 500 mg twice daily for 3 days (adults); weight-based for children.
Well-tolerated and effective, particularly in pediatric cases.
Gastroenterology
Diagnosis: Identifying the infection through stool tests (e.g., antigen detection, microscopy) to confirm the presence of Giardia cysts or trophozoites.
Acute Treatment: Administering appropriate anti-parasitic medications, such as metronidazole, tinidazole, or nitazoxanide, to kill the Giardia organisms.
Symptom Management: Addressing symptoms like diarrhea, abdominal pain, and bloating with supportive care, including rehydration and electrolyte balance.
Follow-Up: Monitoring for resolution of symptoms and re-testing if needed, especially if symptoms persist or recur.
Prevention: Advising on hygiene practices, safe drinking water, and avoiding contaminated food to prevent re-infection or spread.
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
Digital Certificate PDF
On course completion, you will receive a full-sized presentation quality digital certificate.
medtigo Simulation
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.
medtigo Points
medtigo points is our unique point redemption system created to award users for interacting on our site. These points can be redeemed for special discounts on the medtigo marketplace as well as towards the membership cost itself.
Community Forum post/reply = 5 points
*Redemption of points can occur only through the medtigo marketplace, courses, or simulation system. Money will not be credited to your bank account. 10 points = $1.
All Your Certificates in One Place
When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.
